To explore whether a CT-based AI framework, leveraging multi-scale features, can offer a non-invasive approach to accurately predict pathological grade and Ki67 index in clear cell renal cell carcinoma (ccRCC). This evidence concerns the gene MKI67 and nonpapillary renal cell carcinoma.